WHO classification of uterine tumours

Changed by Joshua Yap, 12 Aug 2022
Disclosures - updated 15 Jul 2022: Nothing to disclose

Updates to Article Attributes

Title was changed:
Malignant neoplasms involving the uterusWHO classification of uterine tumours
Body was changed:

The Malignant neoplasms involvingWorld Health Organisation (WHO) classification of tumours of the uterusuterine corpus accountis a commonly used classification system for a significant proportionuterine tumours. It is part of allthe 5th edition WHO classification of female cancersgenital tumours, published in 2020 1.

They can be classified as:

Classification

Endometrial epithelial tumours and precursors
Tumour-like lesions
Mesenchymal tumours of the uterus
  • -<p><strong>Malignant neoplasms involving the uterus</strong> account for a significant proportion of all female cancers.</p><p>They can be classified as:</p><ul>
  • +<p>The <strong>World Health Organisation (WHO) classification of tumours of the uterine corpus</strong> is a commonly used classification system for uterine tumours. It is part of the 5<sup>th</sup> edition WHO classification of female genital tumours, published in 2020 <sup>1</sup>. </p><h4>Classification</h4><h5>Endometrial epithelial tumours and precursors</h5><ul>
  • +<li>precursor lesions<ul>
  • -<a href="/articles/endometrial-carcinoma">endometrial carcinoma</a> : commonest: &gt;90% of all uterine malignancies<ul>
  • -<li>
  • -<a href="/articles/endometrioid-adenocarcinoma-of-the-endometrium">endometrioid carcinoma of the uterus</a>: commonest histological type, ~80%</li>
  • -<li>
  • -<a href="/articles/papillary-serous-carcinoma-of-the-uterus">papillary serous carcinoma of the uterus</a>: ~15%</li>
  • +<a href="/articles/endometrial-hyperplasia-1">endometrial hyperplasia</a> without atypia</li>
  • +<li>endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia</li>
  • +</ul>
  • +</li>
  • -<a href="/articles/clear-cell-carcinoma-of-the-uterus">clear cell carcinoma of the uterus</a>: ~1-5.5%</li>
  • +<a href="/articles/endometrial-carcinoma">endometrial carcinomas</a>: commonest, &gt;90% of all uterine malignancies<ul>
  • -<a href="/articles/adenosquamous-carcinoma-of-the-uterus">adenosquamous carcinoma of the uterus</a>: ~2%</li>
  • +<a href="/articles/endometrioid-adenocarcinoma-of-the-endometrium">endometrioid carcinoma</a>: commonest histological subtype</li>
  • -<a href="/articles/adenocarcinoma-of-the-uterus-with-squamous-differentiation">adenocarcinoma of the uterus with squamous differentiation</a>: 0.25-0.5%</li>
  • -<li>undifferentiated carcinoma of the endometrium<ul><li>small cell undifferentiated carcinoma of the endometrium</li></ul>
  • -</li>
  • -</ul>
  • -</li>
  • +<a href="/articles/papillary-serous-carcinoma-of-the-uterus">serous carcinoma</a>: ~10%</li>
  • -<a href="/articles/uterine-sarcoma">uterine sarcoma: </a>~5% of all uterine malignancies<ul>
  • -<li>mixed<ul>
  • +<a href="/articles/clear-cell-carcinoma-of-the-uterus">clear cell carcinoma</a>: &lt;10%</li>
  • -<a href="/articles/malignant-mixed-mullerian-tumour-of-the-uterus-1">malignant mixed Mullerian tumour of the uterus </a> previously known as<a href="/articles/malignant-mixed-mullerian-tumour-of-the-uterus-1"> </a><a href="/articles/carcinosarcoma-of-the-uterus">carcinosarcoma of the uterus</a>
  • -</li>
  • +<a href="/articles/undifferentiated-carcinoma-of-the-endometrium">undifferentiated and dedifferentiated carcinomas</a>: ~2%</li>
  • +<li>mixed carcinoma: ~10%</li>
  • +<li>other endometrial carcinomas: rare (includes mesonephric adenocarcinoma (~1%), mesonephric-like adenocarcinoma, squamous cell carcinoma (&lt;5%), mucinous carcinoma) </li>
  • -<a href="/articles/adenosarcoma">adenosarcoma</a> of the uterus </li>
  • -<li>mixed <a href="/articles/uterine-leiomyosarcoma">uterine leiomyosarcoma</a> and <a href="/articles/endometrial-stromal-tumours-1">endometrial stromal sarcoma</a>
  • +<a href="/articles/carcinosarcoma-of-the-uterus">carcinosarcoma</a>: previously known as a malignant mixed Müllerian tumour (~5% of all uterine malignancies)</li>
  • +</ul>
  • +</ul><h5>Tumour-like lesions</h5><ul>
  • +<li><a href="/articles/endometrial-polyp">endometrial polyp</a></li>
  • +<li>endometrial metaplasia</li>
  • +<li>Arias-Stella reaction</li>
  • +</ul><h5>Mesenchymal tumours of the uterus</h5><ul>
  • +<li>smooth muscle tumours<ul>
  • +<li><a href="/articles/uterine-leiomyoma">uterine leiomyoma</a></li>
  • +<li><a href="/articles/intravenous-leiomyomatosis">intravenous leiomyomatosis</a></li>
  • +<li><a href="/articles/uterine-smooth-muscle-tumours-of-uncertain-malignant-potential">smooth muscle tumour of uncertain malignant potential</a></li>
  • +<li><a href="/articles/benign-metastasising-leiomyoma">metastasising leiomyoma</a></li>
  • +<li><a href="/articles/uterine-leiomyosarcoma">uterine leiomyosarcoma</a></li>
  • -<li>pure<ul>
  • -<li>
  • -<a href="/articles/uterine-leiomyosarcoma">uterine leiomyosarcoma</a>: ~33-50% of sarcomas</li>
  • -<a href="/articles/endometrial-stromal-tumours-1">endometrial stromal sarcoma</a>: ~10% of sarcomas </li>
  • -<li>
  • -<a href="/articles/fibrosarcoma-of-the-uterus">fibrosarcoma of the uterus</a>: rare</li>
  • -<li>
  • -<a href="/articles/rhabdomyosarcoma-of-the-uterus">rhabdomyosarcoma of the uterus</a>: rare</li>
  • -<li>
  • -<a href="/articles/liposarcoma-of-the-uterus">liposarcoma of the uterus</a>: rare</li>
  • -<li>
  • -<a href="/articles/angiosarcoma-of-the-uterus">angiosarcoma of the uterus</a>: rare</li>
  • +<a href="/articles/endometrial-stromal-tumours-1">endometrial stromal and related tumours</a><ul>
  • +<li>endometrial stromal nodule</li>
  • +<li>low-grade endometrial stromal sarcoma</li>
  • +<li>high-grade endometrial stromal sarcoma</li>
  • +<li>undifferentiated uterine sarcoma</li>
  • +<li>miscellaneous mesenchymal tumours<ul>
  • +<li>uterine tumour resembling ovarian sex cord tumour</li>
  • +<li><a href="/articles/perivascular-epithelioid-cell-tumours-pecomas-1">perivascular epithelioid cell tumour (PEComa)</a></li>
  • +<li><a href="/articles/inflammatory-myofibroblastic-tumour">inflammatory myofibroblastic tumour</a></li>
  • +<li>other mesenchymal tumours of the uterus: rare (includes vascular tumours, lipomatous tumours, <a href="/articles/alveolar-soft-part-sarcoma-2">alveolar soft part sarcoma</a>, <a href="/articles/solitary-fibrous-tumour">solitary fibrous tumour</a>, nerve sheath tumours, NTRK sarcomas, <a href="/articles/giant-cell-tumour-of-soft-tissue">giant cell tumour</a>)</li>
  • +</ul><h5>Mixed epithelial and mesenchymal tumours</h5><ul>
  • +<li><a href="/articles/adenomyoma">adenomyoma</a></li>
  • +<li>atypical polypoid adenomyoma</li>
  • +<li>adenosarcoma of the uterus </li>
  • +</ul><h5>Miscellaneous tumours</h5><ul>
  • +<li>central primitive neuroectodermal tumour / CNS embryonal tumour</li>
  • +<li><a href="/articles/germ-cell-tumours">germ cell tumours</a></li>
  • +</ul><h4>Other</h4><p>Tumours involving the uterus but classified elsewhere (i.e. not of the uterine corpus)​:</p><ul>
  • -<a href="/articles/gestational-trophoblastic-tumours">gestational trophoblastic tumours</a><ul><li><a href="/articles/choriocarcinoma-of-uterus">choriocarcinoma of uterus</a></li></ul>
  • +<a href="/articles/gestational-trophoblastic-tumours">gestational trophoblastic disease</a>: including <a href="/articles/gestational-choriocarcinoma">gestational choriocarcinoma</a>
  • -<a href="/articles/uterine-lymphoma">uterine lymphoma </a><ul>
  • -<li><a href="/articles/primary-uterine-lymphoma">primary uterine lymphoma</a></li>
  • -<li><a href="/articles/secondary-involvment-of-the-uterus-by-lymphoma">secondary involvement of the uterus by lymphoma</a></li>
  • -</ul>
  • -</li>
  • -<li>malignancies that are not of the uterus, but can involve the uterus<ul><li>invasion of the uterus by<ul>
  • -<li><a href="/articles/cervical-carcinoma">cervical carcinoma</a></li>
  • -<li><a href="/articles/primary-vaginal-carcinoma">vaginal carcinoma</a></li>
  • +<a href="/articles/uterine-lymphoma">uterine lymphoma</a>: rare (primary or secondary)</li>
  • +<li>local invasion from other tumours:<ul>
  • +<li><a href="/articles/bladder-cancer">bladder carcinoma</a></li>
  • +<li><a href="/articles/colorectal-cancer-1">colorectal carcinoma</a></li>
  • -<li><a href="/articles/colorectal-carcinoma">colorectal carcinoma</a></li>
  • -<li><a href="/articles/cancers-from-the-bladder">cancers from the bladder</a></li>
  • +<li><a href="/articles/primary-vaginal-carcinoma">vaginal carcinoma</a></li>
  • +<li><a href="/articles/cervical-carcinoma">cervical carcinoma</a></li>
  • -</li></ul>
  • -<a href="/articles/metastases-to-the-uterus">metastases to the uterus</a> from a non-gynaecological malignancy (rare but if it does occur, it is most commonly breast or stomach <sup>3</sup>)</li>
  • -</ul><h4>See also</h4><ul><li><a title="Uterine smooth muscle tumours of uncertain malignant potential" href="/articles/uterine-smooth-muscle-tumours-of-uncertain-malignant-potential">uterine smooth muscle tumours of uncertain malignant potential</a></li></ul>
  • +<a href="/articles/metastases-to-the-uterus">metastases to the uterus</a>: rare</li>
  • +</ul>

References changed:

  • 1. W. H. O. Classification WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Female Genital Tumours: Who Classification of Tumours. (2020) ISBN: 9789283245049 - <a href="http://books.google.com/books?vid=ISBN9789283245049">Google Books</a>
  • 2. Sohaib SA, Verma H, Attygalle AD et-al. Imaging of uterine malignancies. Semin. Ultrasound CT MR. 2010;31 (5): 377-87. <a href="http://dx.doi.org/10.1053/j.sult.2010.07.005">doi:10.1053/j.sult.2010.07.005</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/20974357">Pubmed citation</a><div class="ref_v2"></div>
  • 3. Akin O, Mironov S, Pandit-taskar N et-al. Imaging of uterine cancer. Radiol. Clin. North Am. 2007;45 (1): 167-82. <a href="http://dx.doi.org/10.1016/j.rcl.2006.10.009">doi:10.1016/j.rcl.2006.10.009</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/17157628">Pubmed citation</a><div class="ref_v2"></div>
  • 4. Kido A, Togashi K, Koyama T et-al. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics. 23 (6): 1423-39. <a href="http://dx.doi.org/10.1148/rg.236035033">doi:10.1148/rg.236035033</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/14615554">Pubmed citation</a><div class="ref_v2"></div>
  • 5. Lee EJ, Byun JY, Kim BS et-al. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. Radiographics. 19 (4): 937-45. <a href="http://radiographics.rsna.org/content/19/4/937.full">Radiographics (full text)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/10464801">Pubmed citation</a><div class="ref_v2"></div>
  • 1. Sohaib SA, Verma H, Attygalle AD et-al. Imaging of uterine malignancies. Semin. Ultrasound CT MR. 2010;31 (5): 377-87. <a href="http://dx.doi.org/10.1053/j.sult.2010.07.005">doi:10.1053/j.sult.2010.07.005</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/20974357">Pubmed citation</a><div class="ref_v2"></div>
  • 2. Akin O, Mironov S, Pandit-taskar N et-al. Imaging of uterine cancer. Radiol. Clin. North Am. 2007;45 (1): 167-82. <a href="http://dx.doi.org/10.1016/j.rcl.2006.10.009">doi:10.1016/j.rcl.2006.10.009</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/17157628">Pubmed citation</a><div class="ref_v2"></div>
  • 3. Kido A, Togashi K, Koyama T et-al. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics. 23 (6): 1423-39. <a href="http://dx.doi.org/10.1148/rg.236035033">doi:10.1148/rg.236035033</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/14615554">Pubmed citation</a><div class="ref_v2"></div>
  • 4. Lee EJ, Byun JY, Kim BS et-al. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. Radiographics. 19 (4): 937-45. <a href="http://radiographics.rsna.org/content/19/4/937.full">Radiographics (full text)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/10464801">Pubmed citation</a><div class="ref_v2"></div>
Images Changes:

Image 1 CT (C+ portal venous phase) ( update )

Caption was changed:
Case 1: leiomyosarcoma of the uterus

Image 2 MRI (T2) ( update )

Caption was changed:
Case 2: malignanct mixed Mullerian tumourcarcinosarcoma

Updates to Synonym Attributes

Updates to Synonym Attributes

Updates to Link Attributes

Title was removed:
Malignant neoplasms involving the uterus
Type was removed.
Visible was set to .

Updates to Primarylink Attributes

Updates to Synonym Attributes

Updates to Synonym Attributes

Visible was set to .

Updates to Synonym Attributes

Visible was set to .

Updates to Synonym Attributes

Updates to Synonym Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.